Rani Therapeutics Holdings, Inc.RANINASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank91
5Y CAGR+13.2%
Year-over-Year Change
Year-over-year operating income growth rate
5Y CAGR
+13.2%/yr
Long-term compound
Percentile
P91
Near historical high
vs 5Y Ago
1.9x
Solid growth
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 30.92% |
| Q2 2025 | 12.55% |
| Q1 2025 | 19.69% |
| Q4 2024 | -26.77% |
| Q3 2024 | 5.79% |
| Q2 2024 | 10.76% |
| Q1 2024 | -4.47% |
| Q4 2023 | 24.76% |
| Q3 2023 | 2.40% |
| Q2 2023 | -10.77% |
| Q1 2023 | 5.53% |
| Q4 2022 | -6.98% |
| Q3 2022 | -3.12% |
| Q2 2022 | -15.00% |
| Q1 2022 | -3.13% |
| Q4 2021 | 51.90% |
| Q3 2021 | -428.36% |
| Q2 2021 | -1.15% |
| Q1 2021 | -5.14% |
| Q4 2020 | -74.89% |
| Q3 2020 | 16.61% |
| Q2 2020 | 37.04% |
| Q1 2020 | 0.00% |